TransMedics, headquartered in Andover, Mass., is a medical technology company that offers transplant services, including its Organ Care System (OCS), a portable organ preservation system that ...

New York, New York-- (Newsfile Corp. - March 17, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) ...

(“TransMedics” or “the Company”) (NASDAQ: TMDX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal ...

Please view our affiliate disclosure. Creating a strong brand identity is one of the most important aspects of a business. A well-designed logo is often the first impression a company makes on ...

TransMedics Group Inc (NASDAQ:TMDX) reported a strong Q4 2024 with total revenue of $121.6 million, representing approximately 50% growth year over year. The company's US revenue grew 11% ...

Good afternoon, and welcome to the TransMedics Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. We will be facilitating a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

TransMedics (TMDX) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.12 per share a year ago.

ANDOVER, Mass. (AP) — ANDOVER, Mass. (AP) — TransMedics Group Inc. (TMDX) on Thursday reported fourth-quarter profit of $6.9 million. On a per-share basis, the Andover, Massachusetts-based ...

(NASDAQ: TMDX) between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class Period"), of the important April 15, 2025 lead plaintiff deadline in the securities class action ...